SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-105229
Filing Date
2022-10-03
Accepted
2022-10-03 16:02:16
Documents
12
Period of Report
2022-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2227231d1_8k.htm   iXBRL 8-K 54835
  Complete submission text file 0001104659-22-105229.txt   231602

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA syn-20220930.xsd EX-101.SCH 3060
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20220930_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20220930_pre.xml EX-101.PRE 22614
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2227231d1_8k_htm.xml XML 3615
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 221287471
SIC: 2834 Pharmaceutical Preparations